1255 Maternal Betamethason Administration Is an Indicator but Not an Independent Risk Factor for Raised 17-Hydroxyprogesterone at Neonatal Screening
Pediatric Research - United States
doi 10.1203/00006450-201011001-01255
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2010
Authors
Publisher
Springer Science and Business Media LLC